Rocket One Inc. (RKTO) is asking shareholders to vote at its virtual annual meeting on December 17, 2026, on six matters: five director nominees, ratification of WithumSmith+Brown, PC for the fiscal year ending December 31, 2026, an equity-plan amendment, an advisory say-on-pay vote, reverse-split authority and an increase in authorized common shares. The Board unanimously recommends “FOR” all six proposals. The director nominees are Robb Knie, David Sarnoff, Wayne Linsley, Jeff Pavell and Chris Camarra.
Subject to shareholder approval, the proposed plan amendment would increase the 2022 plan reserve from 3,091,317 to 6,341,317 shares, an increase of 3,250,000 shares. As of October 22, 2026, 31,317 shares remained available; the company estimates the added shares would represent approximately 9.2% additional potential equity dilution. Separate proposals would authorize the Board, after shareholder approval and before December 17, 2028, to effect a reverse split at a ratio from 1-for-2 to 1-for-15, and increase authorized common shares from 50,000,000 to 100,000,000. Robb Knie’s reported 2025 total compensation was $1,930,080.
Rocket One Inc. (RKTO) will hold its virtual 2026 annual shareholder meeting on December 17, 2026, with six proposals, including director elections, auditor ratification, a say-on-pay vote and three capital-related proposals. Shareholders are asked to increase the 2022 equity plan reserve by 3,250,000 shares, from 3,091,317 to 6,341,317 shares; the proposed limit for shares issued through incentive stock options would also be 6,341,317 shares. Other proposals would authorize a reverse split at a ratio from 1-for-2 to 1-for-15 without reducing authorized shares, and increase authorized common shares from 50,000,000 to 100,000,000.
The board unanimously recommends voting “FOR” all six proposals. The proxy reports Robb Knie’s total compensation as $1,930,080 for 2025, compared with $1,226,792 for 2024.
Rocket One Inc. set its 2026 annual meeting for December 17, 2026, and established deadlines for shareholder proposals and nominations. Proposals for inclusion in the proxy statement are due by close of business on October 1, 2026. Notices for other business under the bylaws are due by close of business on October 5, 2026. Shareholders soliciting proxies for director nominees must provide the required Rule 14a-19 notice by October 19, 2026.
Rocket One Inc. (RKTO) announced that it has entered into a definitive Membership Interest Purchase Agreement to acquire 100% of the issued and outstanding membership interests of Tracer Drone Technologies, LLC, a New Jersey-based provider of drone hardware, software, training, maintenance and managed services. The agreement was executed on September 18, 2026, and the transaction is expected to close following the satisfaction or waiver of customary closing conditions. After closing, Tracer is expected to operate as a wholly owned subsidiary of Rocket One.
Management states that Tracer is currently revenue-generating and is expected to provide a foundation in the drone market with established sales, service, training and customer-support capabilities across public safety, enterprise and first-responder markets. Rocket One highlights potential synergies between Tracer’s operating platform and its Swarm Stage AI and other technology assets to support autonomous, counter-UAS and mission-support applications.
Rocket One Inc. (RKTO), formerly Hoth Therapeutics, reports no revenue and a larger loss while shifting its focus from purely biopharmaceuticals to AI semiconductor infrastructure. For the six months ended June 30, 2026, net loss was $6,527,116 versus $5,675,312 a year earlier, driven by higher research and development and general and administrative expenses.
Total assets increased to $9,584,874 from $7,603,444 at year-end 2025, including cash and cash equivalents of $7,891,911. Operating cash outflow was $6,019,382 for the first half of 2026. The company has an accumulated deficit of $79,406,459, but management states current cash is sufficient to fund operations for at least 12 months from issuance.
Rocket One funded operations through equity: it sold 4,193,178 shares via an at-the-market program for net proceeds of $5,847,063 and completed an April 2026 registered direct and concurrent private placement raising net $1,611,880 and issuing new warrants. Shares outstanding rose to 23,184,634 at June 30, 2026. The company exited its prior crypto asset positions and began reporting two segments: a legacy biopharmaceutical segment and a new AI Infrastructure and Technologies segment.
Rocket One Inc. reported that on August 6, 2026 it received a Nasdaq deficiency notice because its common stock no longer meets Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share for 30 consecutive business days. The notice does not immediately affect trading and the shares continue to trade on The Nasdaq Capital Market under the symbol RKTO.
The company has 180 calendar days, until February 2, 2027, to regain compliance by achieving a closing bid of at least $1.00 for 10 consecutive business days, with the possibility of an additional 180-day period subject to conditions. Rocket One states it will monitor its share price and may consider options such as a reverse stock split. Separately, the company announced acceptance into the Seagate Partner Program, gaining access to enterprise data storage resources as it develops AI infrastructure, space, and defense computing technologies.
Rocket One Inc. increased the maximum aggregate offering price of its common stock issuable under its At The Market Offering Agreement with H.C. Wainwright & Co., LLC to include up to an additional $5,257,000 in shares. This increase is separate from approximately $13,557,905 of shares of common stock that were sold to date pursuant to the same Sales Agreement; this is a baseline figure, not the amount being offered.
The company also filed a Current Prospectus Supplement and obtained a legal opinion from Sheppard Mullin Richter & Hampton LLP regarding the legality of the $5,257,000 in shares of common stock covered by the supplement.
Rocket One Inc. is amending its existing shelf registration to increase the capacity for primary sales of common stock under its Sales Agreement with H.C. Wainwright & Co. It is now offering up to an additional $5,257,000 of common stock, from time to time.
Previously, the company sold 9,825,684 shares for gross proceeds of approximately $13.56 million under this agreement. As of June 2, 2026, public float was about $54,043,646, with 24,897,581 shares outstanding and 24,343,985 held by non-affiliates at $2.22 per share, guiding the one-third public float limit under General Instruction I.B.6 of Form S-3. The last reported sale price on July 27, 2026 was $0.7717 per share.
Rocket One Inc. is expanding its AI infrastructure strategy through a strategic collaboration with Placeve Inc., which includes an initial investment and joint evaluation of Placeve’s AI processor architecture, software platform and machine‑learning technologies for defense, space and intelligent edge computing. Placeve’s photonic‑electronic AI processor technology is being evaluated through NASA’s Materials International Space Station Experiment (MISSE) program aboard the International Space Station.
Rocket One also prepared investor presentation materials outlining three core platforms: a nanomagnetic matrix multiplier compute‑in‑memory accelerator targeting ~5 ns, ~500 aJ multiply‑and‑accumulate operations; skyrmion‑mediated spintronic memory switching in ~1 ns at 100–1,000× lower energy than commercial STT‑MRAM with intrinsic radiation tolerance; and the Swarm Stage AI autonomous swarm defense and training platform with over 2,500 field‑tested formations. Together with its existing biotechnology programs held in a subsidiary, these initiatives support an integrated AI and space‑oriented infrastructure strategy.